H R Kim Selected Research

H R Kim Research Topics

Disease

13	Neoplasms (Cancer) 01/2019 - 04/2000
5	Anaphylaxis (Anaphylactic Shock) 11/2001 - 01/2000
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017 - 10/2000
3	Breast Neoplasms (Breast Cancer) 06/2013 - 01/2001
3	Rectal Neoplasms (Rectal Cancer) 02/2013 - 04/2000
3	Carcinoma (Carcinomatosis) 01/2004 - 07/2000
3	Hypersensitivity (Allergy) 11/2001 - 05/2000
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
2	Anastomotic Leak 01/2020 - 08/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 10/2000
2	Lung Neoplasms (Lung Cancer) 06/2017 - 07/2016
2	Hypoxia (Hypoxemia) 01/2017 - 05/2001
2	Inflammation (Inflammations) 06/2016 - 10/2012
2	Colorectal Neoplasms (Colorectal Cancer) 03/2001 - 07/2000
2	Colonic Neoplasms (Colon Cancer) 09/2000 - 07/2000
2	Cerebral Infarction 06/2000 - 05/2000
2	Infections 04/2000 - 01/2000
1	Iron Deficiencies 01/2022
1	COVID-19 11/2020
1	Pneumonia (Pneumonitis) 11/2020
1	Esophageal Squamous Cell Carcinoma 05/2020
1	Atopic Dermatitis (Atopic Eczema) 09/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2016
1	Enteritis 05/2014
1	Adenocarcinoma of Lung 09/2013
1	Fever (Fevers) 08/2013
1	Disease Progression 08/2013
1	Esophageal Neoplasms (Esophageal Cancer) 08/2013
1	Triple Negative Breast Neoplasms 06/2013
1	Spontaneous Fractures (Pathological Fracture) 03/2013
1	Margins of Excision 02/2013
1	Wounds and Injuries (Trauma) 02/2013
1	Flatulence 02/2013
1	Thymoma (Thymic Carcinoma) 01/2012
1	Myasthenia Gravis 01/2012
1	Hemangiosarcoma (Angiosarcoma) 04/2009
1	Hepatitis B 04/2009
1	Bone Resorption 03/2006
1	Body Weight (Weight, Body) 02/2004
1	Necrosis 02/2002

Drug/Important Bio-Agent (IBA)

7	Immunoglobulin E (IgE)IBA 11/2001 - 01/2000
5	AntigensIBA 01/2008 - 06/2000
5	p-Methoxy-N-methylphenethylamineIBA 04/2001 - 01/2000
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2000
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2002 - 05/2000
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 06/2000
2	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2013
2	Oxygen (Dioxygen)IBA 11/2020 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 04/2009 - 07/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2006 - 09/2001
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2001 - 04/2000
2	CytokinesIBA 08/2001 - 05/2000
2	CarbohydratesIBA 09/2000 - 07/2000
2	MucinsIBA 09/2000 - 07/2000
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2000 - 01/2000
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	NivolumabIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2019
1	AllergensIBA 09/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018
1	trametinibIBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	NVP-BKM120IBA 01/2018
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 07/2016
1	Phosphotransferases (Kinase)IBA 07/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2016
1	AntioxidantsIBA 05/2014
1	SeleniumIBA 05/2014
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	Docetaxel (Taxotere)FDA Link 06/2013
1	human ERBB2 proteinIBA 06/2013
1	Hormones (Hormone)IBA 06/2013
1	InterleukinsIBA 10/2012
1	theasinensin AIBA 01/2008
1	Carbon MonoxideIBA 03/2006
1	salicylhydroxamic acid (SHAM)IBA 02/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2004
1	Superoxide DismutaseIBA 01/2004
1	Substance PIBA 02/2002
1	LipopolysaccharidesIBA 02/2002

Therapy/Procedure

8	Therapeutics 11/2020 - 04/2000
4	Neoadjuvant Therapy 08/2013 - 04/2000
3	Length of Stay 01/2022 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 04/2009
2	Esophagectomy 05/2020 - 08/2013
2	Laparotomy 02/2013 - 01/2000
1	Artificial Respiration (Mechanical Ventilation) 11/2020
1	Time-to-Treatment 01/2019
1	Immunotherapy 09/2018
1	Pneumonectomy (Lung Volume Reduction) 04/2016
1	Peritoneal Dialysis 03/2013
1	Catheters 03/2013
1	Operative Time 02/2013
1	Sternotomy 01/2012
1	Thymectomy 01/2012